ITMCTR2100004746尚未招募1 期
The study of intraperitoneal hyperthermic perfusion chemotherapy combined with traditional Chinese medicine on survival status after laparoscopic ovarian cancer reduction surgery
Chengdu Women's and Children's Central Hospital0 个研究点开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional study
入排标准
- 年龄范围
- 30 至 70（—）
- 性别
- Female
入选标准
- •1) Initial treatment of ovarian cancer (including rare types of ovarian tumors);
- •2) Used for neoadjuvant chemotherapy and second HIPEC after intermittent cytoreductive surgery.
- •3) Patients with epithelial ovarian cancer diagnosed by postoperative histopathology;
- •4) Estimated survival time >= 6 months;
- •5) Informed consent of the patient and family members, and signed informed consent form for hyperthermic perfusion.
排除标准
- •1) Intestinal obstruction, extensive adhesions in the peritoneal cavity, and obvious inflammation in the abdominal cavity;
- •2) There may be a high risk of poor postoperative anastomotic healing;
- •Factors, including anastomotic tissue edema, ischemia, obvious tension, severe hypoproteinemia, etc.;
- •3) Major organ dysfunction such as heart, kidney, liver, and brain;
- •4) Severe coagulation dysfunction; bile obstruction and ureteral obstruction;
- •5) Aged >= 75 years old is a relative contraindication.
研究者
相似试验
进行中（未招募）
不适用
Feasibility study of hyperthermic intraperitoneal chemotherapy (HIPEC) for patients with stage III or only pleural stage IV ovarian carcinoma in first line therapy. - HIPEC-ovarian carcinomaInclusion criteria :1. Histologically confirmed ovarian carcinoma or primary peritoneal carcinoma or Fallopian tube carcinoma.2. FIGO stage III disease or only pleural stage IV disease3. Age less than 65 years4. ECOG performance status 0-1.5. Adequate bone marrow, hepatic and renal functions.6. No serious cardiac or respiratory illnessEUCTR2009-009467-59-BEInstitut Jules Bordet
招募中
不适用
Study of Hyperthermic intraperitoneal chemotherapy(HIPEC) for peritoneal dissemination and appendiceal mucinous neoplasmJPRN-UMIN000016360Mie university gastrointestinal and pediatric surgery10
进行中（未招募）
不适用
ovarian cancer treatment with intraabdominal chemotherapy (paclitaxel)EUCTR2011-006319-69-ESPedro Villarejo Campos(Hospital Universitario Ciudad Real)
已完成
不适用
Safety and efficacy of heated chemotherapy given during surgery in management of gall bladder cancerCTRI/2018/02/011879I45
进行中（未招募）
不适用
Surgery plus intraperitoneal Hypertermic chemotherapy in platinum-sensitive patients with ovarian cancer recurrence after 12 months. Phase II studyRecurrent ovarian cancerMedDRA version: 6.1Level: PTClassification code 10033128EUCTR2005-000927-41-ITPOLICLINICO UNIVERSITARIO AGOSTINO GEMELLI